Sacubitril/valsartan improves functional class and objective parameters in heart failure patients with reduced ejection fraction and its discontinuation is associated with a poor prognosis.
26 May 2018 (00:00 - 00:00)
Organised by:
About the speaker
12th of October University Hospital, Madrid (Spain)
38 More presentations in this session
Miss M. Vester (Leiden, NL)
Associate Professor O. Havakuk (Tel Aviv, IL)
Professor Z. RAISSUNI (Tanger, MA)
Access the full session
The Event
Heart Failure 2018
26 May - 29 May 2018
